The included (N = 627) and excluded (N = 950) patients were compared for age, tumour grade, histological type, T-stage, N-stage, hormone receptor status, HER2 status, type of operation, radiotherapy, chemotherapy and hormonal therapy. This evidence concerns the gene NR4A1 and neoplasm.